EDSA dip buy opportunity! close to 100% retracement

ZombieStar Updated   
NASDAQ:EDSA   Edesa Biotech, Inc.
Yesterday they knocked EDSA out of the ball park to $19! today it is close to where it started from two days prior. Great opportunity for a possible final boss round (Phase 3). Very good phase 3 results often 10x a company's stock price. EDSA is currently phase 1 and phase 2.

COVID news had EDSA gap up to $19 and as long as COVID is front and center stage, anything having to do with the virus will do well in this market.

Price target: $15.99


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.